Galrão AL - Search Results

1

Levothyroxine absorption in morbidly obese patients before and after Roux-En-Y gastric bypass (RYGB) surgery.

Rubio IG, Galrão AL, Santo MA, Zanini AC, Medeiros-Neto G. Rubio IG, et al. Among authors: galrao al. Obes Surg. 2012 Feb;22(2):253-8. doi: 10.1007/s11695-011-0452-8. Obes Surg. 2012. PMID: 21633823

2

Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil.

Camargo RY, Tomimori EK, Neves SC, G S Rubio I, Galrão AL, Knobel M, Medeiros-Neto G. Camargo RY, et al. Among authors: galrao al. Eur J Endocrinol. 2008 Sep;159(3):293-9. doi: 10.1530/EJE-08-0192. Epub 2008 Jun 27. Eur J Endocrinol. 2008. PMID: 18586897

3

A molecular analysis and long-term follow-up of two siblings with severe congenital hypothyroidism carrying the IVS30+1G>T intronic thyroglobulin mutation.

Rubio IG, Galrao AL, Pardo V, Knobel M, Possato RF, Camargo RR, Ferreira MA, Kanamura CT, Gomes SA, Medeiros-Neto G. Rubio IG, et al. Among authors: galrao al. Arq Bras Endocrinol Metabol. 2008 Nov;52(8):1337-44. doi: 10.1590/s0004-27302008000800022. Arq Bras Endocrinol Metabol. 2008. PMID: 19169491

4

Hypermethylation of a New Distal Sodium/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors.

Galrão AL, Camargo RY, Friguglietti CU, Moraes L, Cerutti JM, Serrano-Nascimento C, Suzuki MF, Medeiros-Neto G, Rubio IG. Galrão AL, et al. J Clin Endocrinol Metab. 2014 Jun;99(6):E944-52. doi: 10.1210/jc.2013-1450. Epub 2014 Jan 16. J Clin Endocrinol Metab. 2014. PMID: 24432988

5

HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance.

Lima EU, Rubio IGS, Da Silva JC, Galrão AL, Pêssoa D, Oliveira TC, Carrijo F, Silva Campos I, Fonseca Espinheira L, Sampaio LJ, Lima CR, Cerutti JM, Ramos HE. Lima EU, et al. Among authors: galrao al. Endocr Connect. 2018 Dec;7(12):1333-1342. doi: 10.1530/EC-18-0380. Endocr Connect. 2018. PMID: 30400039 Free PMC article.

6

Transcriptional regulation of the potential tumor suppressor ABI3 gene in thyroid carcinomas: interplay between methylation and NKX2-1 availability.

Moraes L, Galrão AL, Rubió I, Cerutti JM. Moraes L, et al. Among authors: galrao al. Oncotarget. 2016 May 3;7(18):25960-70. doi: 10.18632/oncotarget.8416. Oncotarget. 2016. PMID: 27036019 Free PMC article.

7

Methylation levels of sodium-iodide symporter (NIS) promoter in benign and malignant thyroid tumors with reduced NIS expression.

Galrão AL, Sodré AK, Camargo RY, Friguglietti CU, Kulcsar MA, Lima EU, Medeiros-Neto G, Rubio IG. Galrão AL, et al. Endocrine. 2013 Feb;43(1):225-9. doi: 10.1007/s12020-012-9779-8. Epub 2012 Sep 1. Endocrine. 2013. PMID: 22945693

8

Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.

Sodré AK, Rubio IG, Galrão AL, Knobel M, Tomimori EK, Alves VA, Kanamura CT, Buchpiguel CA, Watanabe T, Friguglietti CU, Kulcsar MA, Medeiros-Neto G, Camargo RY. Sodré AK, et al. Among authors: galrao al. J Clin Endocrinol Metab. 2008 Oct;93(10):4141-5. doi: 10.1210/jc.2007-0353. Epub 2008 Jul 15. J Clin Endocrinol Metab. 2008. PMID: 18628528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters